Combivent® Respimat®

ipratropium bromide, salbutamol, sulphate

About Combivent® Respimat®

A combination of a short-acting anticholinergic and beta-adrenergic for the management of reversible bronchospasms associated with obstructive airway diseases in patients requiring more than one bronchodilator.


 

 

Professional Area

You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.

Product Key Facts

Indications

Reversible bronchospasms associated with obstructive airway diseases

Brand Names

Combivent® Respimat®

Active ingredients

ipratropium bromide, salbutamol, sulphate